New evidence for teriflunomide in multiple sclerosis

被引：3
|
作者：
Kieseier, Bernd C. [1 ]
Wiendl, Heinz [2 ]
机构：
[1] Univ Dusseldorf, Dept Neurol, Fac Med, D-40225 Dusseldorf, Germany
[2] Univ Munster, Dept Neurol, D-48149 Munster, Germany
来源：
LANCET NEUROLOGY | 2014年 / 13卷 / 03期
关键词：
ORAL FINGOLIMOD;
D O I：
10.1016/S1474-4422(14)70012-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：234 / 235
页数：2
相关论文
共 50 条
  • [31] Teriflunomide for multiple sclerosis in real-world setting
    Elkjaer, M. L.
    Molnar, T.
    Illes, Z.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (05): : 447 - 453
  • [32] Teriflunomide -: Agent for multiple sclerosis, dihydroorotate dehydrogenase inhibitor
    Boyd, B
    Castañer, J
    [J]. DRUGS OF THE FUTURE, 2005, 30 (11) : 1102 - 1106
  • [33] New Study Data on Teriflunomide and Alemtuzumab - Experts await Progress in Multiple Sclerosis Therapy
    Vetter, Christine
    [J]. NERVENHEILKUNDE, 2012, 31 (12) : 967 - 968
  • [34] Extending the Potential of the Treatment of Multiple Sclerosis with a New Agent for Oral Use – Teriflunomide (Aubagio)
    Khachanova N.V.
    Gorokhova T.V.
    [J]. Neuroscience and Behavioral Physiology, 2017, 47 (1) : 112 - 116
  • [35] Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
    Andrew Chan
    Jérôme de Seze
    Manuel Comabella
    [J]. CNS Drugs, 2016, 30 : 41 - 51
  • [36] Teriflunomide safety and efficacy in advanced progressive multiple sclerosis
    Ferreira, V. F. Moreira
    Caefer, D.
    Erlich-Malona, N.
    Healy, B.
    Chitnis, T.
    Stankiewicz, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 554 - 555
  • [37] Rapid Onset of Efficacy of Teriflunomide in Patients With Multiple Sclerosis
    Macdonell, R.
    Barnett, M.
    Lechner-Scott, J.
    King, J.
    Truffinet, P.
    Dukovic, D.
    Wolinsky, J. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 820 - 820
  • [38] Effect of teriflunomide on cognitive abilities of patients with multiple sclerosis
    Lizhdvoy, V.
    Kotov, S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 931 - 931
  • [39] Review of teriflunomide and its potential in the treatment of multiple sclerosis
    Warnke, Clemens
    Hoerste, Gerd Meyer Zu
    Hartung, Hans-Peter
    Stueve, Olaf
    Kieseier, Bernd C.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 333 - 340
  • [40] Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
    Sartori, Arianna
    Carle, Dawn
    Freedman, Mark S.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 1019 - 1027
12345